Marshall Wace North America’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $5.19M | Sell |
6,953
-9,918
| -59% | -$7.4M | 0.02% | 494 |
|
|
2021
Q2 | $10.9M | Sell |
16,871
-7,579
| -31% | -$4.88M | 0.05% | 354 |
|
|
2021
Q1 | $14M | Buy |
24,450
+14,311
| +141% | +$8.17M | 0.06% | 334 |
|
|
2020
Q4 | $5.91M | Buy |
+10,139
| New | +$5.91M | 0.03% | 506 |
|
|
2020
Q3 | – | Sell |
-1,631
| Closed | -$736K | – | 1215 |
|
|
2020
Q2 | $736K | Sell |
1,631
-97
| -6% | -$43.8K | ﹤0.01% | 847 |
|
|
2020
Q1 | $605K | Buy |
+1,728
| New | +$605K | ﹤0.01% | 718 |
|
|
2019
Q4 | – | Sell |
-12,109
| Closed | -$4.03M | – | 1294 |
|
|
2019
Q3 | $4.03M | Buy |
+12,109
| New | +$4.03M | 0.02% | 401 |
|
|
2019
Q2 | – | Sell |
-1,933
| Closed | -$591K | – | 1173 |
|
|
2019
Q1 | $591K | Buy |
1,933
+232
| +14% | +$70.9K | ﹤0.01% | 763 |
|
|
2018
Q4 | $395K | Buy |
1,701
+889
| +109% | +$206K | ﹤0.01% | 825 |
|
|
2018
Q3 | $255K | Sell |
812
-2,081
| -72% | -$654K | ﹤0.01% | 814 |
|
|
2018
Q2 | $835K | Sell |
2,893
-1,895
| -40% | -$547K | ﹤0.01% | 975 |
|
|
2018
Q1 | $1.2M | Buy |
4,788
+2,922
| +157% | +$731K | 0.01% | 946 |
|
|
2017
Q4 | $445K | Sell |
1,866
-8,685
| -82% | -$2.07M | ﹤0.01% | 1166 |
|
|
2017
Q3 | $2.34M | Buy |
+10,551
| New | +$2.34M | 0.01% | 755 |
|
|
2017
Q2 | – | Sell |
-1,947
| Closed | -$387K | – | 1294 |
|
|
2017
Q1 | $387K | Buy |
+1,947
| New | +$387K | ﹤0.01% | 843 |
|